Back to search page

TRES20210920001

Looking for new assets in advanced research or preclinical development stages that could be useful for the treatment of dermatological diseases

TECHNOLOGY PROFILE   REQUEST   ADD TO FAVOURITES
PRINT

 

ABSTRACT

A Spanish pharmaceutical company active in the skin care sector is looking for partnering opportunities on new assets in advanced research or preclinical development stages that could be useful for the treatment of dermatological diseases within the frame of a research cooperation agreement or a technical cooperation agreement.

This request refers to an open innovation challenge.


FULL DESCRIPTION

A Spanish pharmaceutical company developing breakthrough innovative products in the field of dermatology to address patientsí unmet needs has launched an open innovation challenge.

They are looking for partnering opportunities on new assets in advanced research or preclinical development stages that could be useful for the treatment of skin diseases.

Preferably, the solution sought should: target immuno-inflammatory pathways or be suitable for dermato-oncological or rare dermatological indications, involve any therapeutic modality and demonstrate strong evidences of efficacy.

The aim of the company is to explore the possibility to establish a long-term business partnership under the frame of a research cooperation agreement or a technical cooperation agreement. Within this collaboration, the Spanish company is looking for:
- Collaborate in the development of new assets in advanced research or preclinical stage
- Apply to research grants
- Characterise further assets in a pre-agreed panel of relevant cellular assays and in vivo models for dermatological diseases

IMPORTANT:
This technology request refers to an innovation challenge published on an online open innovation platform from July 5th, 2021 to October 31st, 2021. Organizations are invited to express their interest using the platform (a secure site to store and manage the proposals) after creating there an account. All the initial information provided under the proposal should be non-confidential. Sharing of confidential information will be made possible on demand. A designated contact person of the Spanish Company will help the interested entity on answering any question

Proposal evaluation and selection:
o A team of Companyís scientific experts will evaluate the proposal as soon as it is received
o The participant will receive in writing their decision regarding the proposal within 8 -10 weeks after submission
o If the proposal has been selected, a member of the Companyís Team will contact the entity behind it to initiate a partnership agreement that will reflect a collaborative proposal, including eventual experimental activities, and/or a business proposal according to the assetís development stage


Partner expertise sought:

- Type of partner sought: Preferably, the assets should:
- Target immuno-inflammatory pathways or be suitable for dermato-oncological or rare dermatological indications
- Involve any therapeutic modality such as small molecules, biologics or advanced therapies
- Demonstrate strong scientific rationale, including in vitro and in vivo evidences of efficacy, if available
- Specific area of activity of the partner: Type: This call is addressed to start-ups, biotechs, universities, research centres, and pharmaceutical companies all over the world working on new assets in advanced research or preclinical development stages that could be useful for the treatment of dermatological diseases.

Role: Within the frame of a research cooperation agreement or a technical cooperation agreement with the Spanish company, the partner sought should be interested in:
o An advanced research or preclinical development collaboration
o Applying for research grants
o A further asset characterization by the Spanish entity in a pre-agreed panel of relevant cellular assays and in vivo models for dermatological diseases

Sign-in or create an account

To express an interest in this profile, you must first sign in or create a new account.

If you already have an account, sign in here

Not got an account yet, sign up here

KEY INFORMATION

Country of origin
SPAIN
Profile date
07/10/2021
Deadline
27/11/2021

PARTNERSHIP(S) SOUGHT

Technical cooperation agreement Research cooperation agreement

CLASSIFICATIONS

INDUSTRY SECTORS
Life Sciences \ Biosciences and Health \ Drug Discovery and Drug Development \ Medical Devices
TECHNOLOGY KEYWORDS
BIOLOGICAL SCIENCES / Medicine, Human Health / Clinical Research, Trials / BIOLOGICAL SCIENCES / Medicine, Human Health / Cytology, Cancerology, Oncology / BIOLOGICAL SCIENCES / Biology / Biotechnology / In vitro Testing, Trials
COMMERCIAL KEYWORDS
none...
MARKET KEYWORDS
GENETIC ENGINEERING/MOLECULAR BIOLOGY / In vitro Testing, Trials / MEDICAL/HEALTH RELATED / Clinical Medicine / Oncology / MEDICAL/HEALTH RELATED / Clinical Medicine / Other clinical medicine / MEDICAL/HEALTH RELATED / Anatomy, Pathology, Immunology, Physiology

FIND OUT MORE

Contact Enterprise Europe Network Scotland by email at info@enterprise-europe-scotland.com, quoting reference number TRES20210920001

Upcoming events

No upcoming events